Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Internal Model Harmonisation Approval

14 Sep 2021 14:07

RNS Number : 7533L
Phoenix Group Holdings PLC
14 September 2021
 

LEI: 2138001P49OLAEU33T68

 

Phoenix Group's Internal Model Harmonisation application is approved by the PRA

 

The Board of Phoenix Group Holdings plc ("the Group") is pleased to announce that the Prudential Regulation Authority ("PRA") has approved its application to harmonise its legacy Phoenix and Standard Life internal models.

 

This single, more sophisticated harmonised Internal Model will provide deeper insights into our risk profile which further strengthens the Group's risk management approach and decision making, as well as delivering significant capital synergies through diversification and improved risk modelling.

 

The harmonised Internal Model will go live effective 30 September 2021 and is currently estimated to increase the Group's Solvency II ("SII") Surplus by c.£0.4 billion. It is expected that c.£0.1 billion of the increased SII Surplus will then emerge as an acceleration of cash in 2022, after an appropriate period of operation.

 

The harmonised Internal Model also delivers a reduced capital strain for the Group's Bulk Purchase Annuity ("BPA") new business and unlocks a wider pipeline of future management actions including the execution of Part VIIs, the delivery of further enhancements to the Group's credit risk modelling capabilities and the foundation to bring ReAssure onto the new Internal Model in time. It will also support the Group in delivering future value accretive M&A.

 

-------------------------------------------------------------------------------------------------------------------------------------------------------

Enquiries

Investors/analysts:

Claire Hawkins, Director of Corporate Affairs, Phoenix Group

+44 (0)20 3735 0575

Andrew Downey, Investor Relations Director, Phoenix Group

+44 (0)20 3735 0160

Media:

Douglas Campbell, Teneo

+44 (0)775 313 6628

Shellie Wells, Corporate Communications Director, Phoenix Group

+44 (0)20 3735 0922

-------------------------------------------------------------------------------------------------------------------------------------------------------

Legal Disclaimers

This announcement in relation to Phoenix and its subsidiaries (the "Group") contains forward-looking statements about the Group's current plans, goals and expectations relating to future financial events, conditions, performance, results, strategy and/or objectives. Statements containing the words: 'believes', 'intends', 'will', 'expects', 'may', 'should', 'plans', 'aims', 'seeks', 'continues', 'targets' and 'anticipates' or other words of similar meaning are forward-looking. Such forward-looking statements involve risk and uncertainty because they relate to future events and circumstances that are beyond the Group's control. As a result, such future events and the Group's actual future financial condition, performance and results may differ materially from the plans, goals and expectations set out in the forward-looking statements in this announcement. The Group undertakes no obligation to update any of the forward-looking statements contained within this announcement. References in this announcement to Solvency II Surplus should be read in conjunction with the relevant footnotes set out in the 2021 Half Year Results Announcement of 11 August 2021.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
REAGZGMLFDDGMZM
Date   Source Headline
24th Jun 20148:35 amRNSDebt Investment Roadshow
24th Jun 20148:35 amRNSChange in Control Approval
13th Jun 20144:00 pmRNSDirector/PDMR Shareholding
30th May 20144:30 pmRNSTotal Voting Rights
21st May 20144:30 pmRNSDirector/PDMR Shareholding
20th May 20144:30 pmRNSDirector/PDMR Shareholding
13th May 20144:30 pmRNSDirector/PDMR Shareholding
12th May 20144:30 pmRNSDirector/PDMR Shareholding
8th May 20145:30 pmRNSDirector/PDMR Shareholding
2nd May 20143:30 pmRNSHolding(s) in Company
1st May 20147:00 amRNSQ1 2014 Interim Management Statement
30th Apr 20144:30 pmRNSTotal Voting Rights
30th Apr 20141:41 pmRNSDirectorate Change
30th Apr 20141:40 pmRNSResult of AGM
30th Apr 201412:00 pmRNSDirector/PDMR Shareholding
28th Apr 20144:00 pmRNSHolding(s) in Company
28th Apr 20142:10 pmRNSCorrection: 2013 Annual Report & Accounts
14th Apr 20144:00 pmRNSDirector/PDMR Shareholding
7th Apr 20144:30 pmRNSBlocklisting Interim Review
2nd Apr 20144:30 pmRNSDirector/PDMR Shareholding
31st Mar 20144:30 pmRNSDirector/PDMR Shareholding
31st Mar 20144:30 pmRNSDirector/PDMR Shareholding
31st Mar 20144:30 pmRNSAGM Statement
28th Mar 20144:43 pmRNSResponse to FCA Statement
26th Mar 20147:01 amRNSDirector/PDMR Shareholding
26th Mar 20147:01 amRNSDirectorate Change
26th Mar 20147:01 amRNSDivestment of Ignis
26th Mar 20147:00 amRNSPhoenix Group Holdings - 2013 Annual Results
24th Mar 20147:00 amRNSStatement re. Press Comment
24th Mar 20147:00 amRNSStatement re. Press Comment
11th Mar 20144:30 pmRNSDirector/PDMR Shareholding
7th Mar 20144:00 pmRNSHolding(s) in Company
28th Feb 20144:30 pmRNSTotal Voting Rights
14th Feb 20145:15 pmRNSHolding(s) in Company
12th Feb 20146:09 pmRNSDirector/PDMR Shareholding
7th Feb 20145:00 pmRNSHolding(s) in Company
31st Jan 20144:00 pmRNSTotal Voting Rights
13th Jan 20145:30 pmRNSDirector/PDMR Shareholding
31st Dec 20131:00 pmRNSTotal Voting Rights
30th Dec 20134:00 pmRNSDirector/PDMR Shareholding
24th Dec 201312:30 pmRNSHolding(s) in Company
17th Dec 20134:00 pmRNSDirector/PDMR Shareholding
12th Dec 20134:00 pmRNSDirector/PDMR Shareholding
11th Dec 20134:30 pmRNSDirector/PDMR Shareholding
11th Dec 20134:30 pmRNSDirector/PDMR Shareholding
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
6th Dec 20137:00 amRNSHolding(s) in Company
2nd Dec 20134:00 pmRNSDirector/PDMR Shareholding
27th Nov 20135:00 pmRNSDirector/PDMR Shareholding
26th Nov 20134:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.